Your browser doesn't support javascript.
loading
Non-integrating gamma-retroviral vectors as a versatile tool for transient zinc-finger nuclease delivery.
Bobis-Wozowicz, Sylwia; Galla, Melanie; Alzubi, Jamal; Kuehle, Johannes; Baum, Christopher; Schambach, Axel; Cathomen, Toni.
Afiliação
  • Bobis-Wozowicz S; 1] Institute for Cell and Gene Therapy, University Medical Center Freiburg, 79108 Freiburg, Germany [2] Center for Chronic Immunodeficiency, University Medical Center Freiburg, 79108 Freiburg, Germany [3] Institute of Experimental Hematology, Hannover Medical School, 30625 Hannover, Germany [4].
  • Galla M; Institute of Experimental Hematology, Hannover Medical School, 30625 Hannover, Germany.
  • Alzubi J; 1] Institute for Cell and Gene Therapy, University Medical Center Freiburg, 79108 Freiburg, Germany [2] Center for Chronic Immunodeficiency, University Medical Center Freiburg, 79108 Freiburg, Germany [3] Institute of Experimental Hematology, Hannover Medical School, 30625 Hannover, Germany.
  • Kuehle J; Institute of Experimental Hematology, Hannover Medical School, 30625 Hannover, Germany.
  • Baum C; Institute of Experimental Hematology, Hannover Medical School, 30625 Hannover, Germany.
  • Schambach A; 1] Institute of Experimental Hematology, Hannover Medical School, 30625 Hannover, Germany [2] Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Cathomen T; 1] Institute for Cell and Gene Therapy, University Medical Center Freiburg, 79108 Freiburg, Germany [2] Center for Chronic Immunodeficiency, University Medical Center Freiburg, 79108 Freiburg, Germany [3] Institute of Experimental Hematology, Hannover Medical School, 30625 Hannover, Germany.
Sci Rep ; 4: 4656, 2014 Apr 11.
Article em En | MEDLINE | ID: mdl-24722320
ABSTRACT
Designer nucleases, like zinc-finger nucleases (ZFNs), represent valuable tools for targeted genome editing. Here, we took advantage of the gamma-retroviral life cycle and produced vectors to transfer ZFNs in the form of protein, mRNA and episomal DNA. Transfer efficacy and ZFN activity were assessed in quantitative proof-of-concept experiments in a human cell line and in mouse embryonic stem cells. We demonstrate that retrovirus-mediated protein transfer (RPT), retrovirus-mediated mRNA transfer (RMT), and retrovirus-mediated episome transfer (RET) represent powerful methodologies for transient protein delivery or protein expression. Furthermore, we describe complementary strategies to augment ZFN activity after gamma-retroviral transduction, including serial transduction, proteasome inhibition, and hypothermia. Depending on vector dose and target cell type, gene disruption frequencies of up to 15% were achieved with RPT and RMT, and >50% gene knockout after RET. In summary, non-integrating gamma-retroviral vectors represent a versatile tool to transiently deliver ZFNs to human and mouse cells.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Técnicas de Transferência de Genes / Endonucleases / Vetores Genéticos Limite: Animals / Humans Idioma: En Revista: Sci Rep Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Técnicas de Transferência de Genes / Endonucleases / Vetores Genéticos Limite: Animals / Humans Idioma: En Revista: Sci Rep Ano de publicação: 2014 Tipo de documento: Article